• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Vertex Pharmaceuticals (NQ:VRTX)

    438.59 -0.12 (-0.03%)
    Streaming Delayed Price Updated: 11:33 AM EDT, Apr 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Vertex Pharmaceuticals

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    72 73 Next >
    Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Growth and Technical Setup ↗
    Via Chartmill
    News headline image
    1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
    Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have ou... 
    Via StockStory
    News headline image
    Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
    From Vertex Pharmaceuticals Incorporated
    Via Business Wire
    News headline image
    Biotech Defies Gravity: Sarepta and Corcept Lead Midday Healthcare Rally Amidst Market Volatility
    In a trading session characterized by sharp declines across the technology and industrial sectors, the healthcare industry emerged as a resilient fortress on March 31, 2026. While the broader S&P 500... 
    Via MarketMinute
    Topics Economy Intellectual Property Stocks
    Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Prime GARP Investment ↗
    Via Chartmill
    Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Merges Strong Fundamentals with Bullish Technical Setup ↗
    Via Chartmill
    News headline image
    1 Cash-Producing Stock with Promising Prospects and 2 We Turn Down
    Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
    Via StockStory
    News headline image
    Prediction: The Trump Bull Market Is About to End -- but These Stocks Will Rise Anyway ↗
    Some stocks can zig when the overall market zags. 
    Via The Motley Fool
    Topics Economy Energy Government
    News headline image
    2 Stocks I Plan to Hold for the Next 20 Years ↗
    These companies help me sleep peacefully at night. 
    Via The Motley Fool
    Topics Intellectual Property
    Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below. ↗
    Via Chartmill
    News headline image
    2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds
    Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are... 
    Via StockStory
    News headline image
    Where Will Vertex Pharmaceuticals Be in 1 Year? ↗
    The biotech's recent dip might be a buying opportunity. 
    Via The Motley Fool
    News headline image
    CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now? ↗
    The gene-editing stock has been in a tailspin of late. 
    Via The Motley Fool
    News headline image
    New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
    Via ACCESS Newswire
    News headline image
    Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026
    As of March 20, 2026, Vertex Pharmaceuticals (NASDAQ: VRTX) has officially transcended its long-held identity as "the cystic fibrosis (CF) company." For over a decade, the Boston-based biotech giant... 
    Via Finterra
    Topics Intellectual Property
    News headline image
    Is CRISPR Therapeutics Stock a Buy Now? ↗
    We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates. 
    Via The Motley Fool
    News headline image
    My Top 3 Drug Stocks for March 2026 ↗
    These companies have impressive track records of navigating the biggest challenges in their industry. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals ↗
    Both have plenty to offer investors, but one has a better outlook. 
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks
    As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Vertex Pharmaceuticals (NASD... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    1 Momentum Stock to Research Further and 2 We Ignore
    The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab... 
    Via StockStory
    News headline image
    Is Vertex Pharmaceuticals Heading to $600? ↗
    A new product approval may be right around the corner. 
    Via The Motley Fool
    News headline image
    This Stock Just Jumped By 8%: Is It Too Late to Buy? ↗
    The drugmaker is getting its mojo back. 
    Via The Motley Fool
    News headline image
    2 Reasons to Watch VRTX and 1 to Stay Cautious
    Vertex Pharmaceuticals’s 22.2% return over the past six months has outpaced the S&P 500 by 19.8%, and its stock price has climbed to $480.31 per share. This ... 
    Via StockStory
    Topics Stocks
    News headline image
    Vertex Pharmaceuticals Surges 8.3% as Renal Breakthrough Sparks Market Rally
    In a significant milestone for precision medicine, Vertex Pharmaceuticals (NASDAQ:VRTX) emerged as the top performer in the S&P 500 on March 11, 2026, with its shares climbing 8.3%. The rally followed... 
    Via MarketMinute
    Topics Stocks
    News headline image
    Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc
    Check out the companies making headlines yesterday: nLIGHT (NASDAQ:LASR): Laser company nLIGHT (NASDAQ:LASR) rose by 5.5% on Tuesday after the market reacted... 
    Via StockStory
    Topics Artificial Intelligence
    Explore the top gainers and losers within the S&P500 index in today's session. ↗
    Via Chartmill
    News headline image
    Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today
    What Happened? Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 8.3% in the afternoon session after the company announced positive resul... 
    Via StockStory
    Topics Economy
    News headline image
    The Great Biotech Divide: Vertex Soars on Multi-Franchise Breakthroughs as Novo Nordisk Stumbles in the Weight-Loss War
    The healthcare sector has entered a period of sharp divergence in early 2026, creating a "bifurcated market" where clinical innovation is rewarding a select few while punishing former industry... 
    Via MarketMinute
    News headline image
    Vertex Pharmaceuticals Surges as Breakthrough Kidney Data Sets New Gold Standard for IgA Nephropathy
    Shares of Vertex Pharmaceuticals (Nasdaq: VRTX) climbed more than 8% today, reaching a record high as the biotechnology giant unveiled spectacular interim results from its pivotal Phase 3 RAINIER... 
    Via MarketMinute
    Which S&P500 stocks are moving on Tuesday? ↗
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    72 73 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.